Organization-based performance measures of cancer care quality: core measure development for breast cancer in Taiwan

European Journal of Cancer Care
K-P ChungP-C Hsieh

Abstract

The purpose of the study was to develop organization-based core performance measures (CPMs) for breast cancer patients treated in hospitals that participated in cancer quality improvement programmes in Taiwan. CPMs were developed in three stages that included a preparation, a consensus building stage, and two stages of stakeholder feedback. Three criteria and seven subcriteria were applied in the development process. Indicators listed in a Delphi questionnaire were based on a literature search, indicators developed by relevant institutions and discussion by authors. Each indicator needed to meet inclusion criteria as a final indicator. Evidence-based guidelines, expert opinions from panel group, 27 hospitals and empirical data were all applied to develop and revise the core measures. Fifteen out of 28 indicators were selected and modified after the three stages. There were two pre-treatment indicators for screening and diagnosis, nine treatment-related indicators, and four monitoring-related indicators. Six indicators were supported by evidence level I, and four indicators by level II evidence. The CPMs for breast cancer can be developed systematically and be applied for internal quality improvement and external surveillance. O...Continue Reading

References

Nov 1, 1987·Journal of Advanced Nursing·C M Goodman
Nov 30, 1995·The New England Journal of Medicine·UNKNOWN Early Breast Cancer Trialists' Collaborative Group
Sep 17, 1994·BMJ : British Medical Journal·N R Hicks
Apr 1, 1994·Medical Care·J P KahanR H Brook
Nov 1, 1993·The Joint Commission Journal on Quality Improvement·D M NadzamR E White
Apr 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M Blichert-ToftN O'Higgins
Jun 12, 1998·JAMA : the Journal of the American Medical Association·A M Epstein
Jun 25, 1998·The New England Journal of Medicine·P G ShekelleR E Park
Jul 14, 1998·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·S L NormandR H Palmer
Aug 6, 1998·Health Affairs·D M Eddy
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J SmithM R Somerfield
Dec 11, 1985·International Journal of Technology Assessment in Health Care·R H BrookR E Park
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S MandelblattK L Kahn
Mar 29, 2001·Annual Review of Public Health·M L BrownC Snyder
Sep 5, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D SchragC B Begg
Jan 5, 2002·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·H R RubinG B Diette
Sep 3, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer L MalinRobert H Brook
Dec 7, 2002·Quality & Safety in Health Care·S M CampbellM Marshall
Jan 25, 2003·Medical Care·Donald M BerwickMolly Joel Coye
Feb 7, 2003·Quality & Safety in Health Care·M N MarshallM O Roland
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin A SpencerMark S Litwin
Oct 22, 2003·Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses·Nancy M Saufl, UNKNOWN Joint Commission on Accreditation of Healthcare Organizations
Dec 9, 2003·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Jan Mainz
Apr 3, 2004·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Jerod M Loeb
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric C SchneiderArnold M Epstein
Aug 21, 2004·Medical Care·Susan A OliveriaPaul Stang
Feb 14, 2006·The Breast : Official Journal of the European Society of Mastology·J M WhelanT Archer

❮ Previous
Next ❯

Citations

Mar 2, 2010·The International Journal of Health Planning and Management·Fauziah RabbaniGoran Tomson
Jun 25, 2015·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Han BaoMeina Liu
Apr 28, 2009·International Journal of Radiation Oncology, Biology, Physics·Benjamin D SmithThomas A Buchholz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.